ライフサイエンスコーパス: birthweight

1 on of placental infection and associated low birthweight.

2 risk of non-communicable diseases after low birthweight.

3 .6 million infants were born at term and low birthweight.

4 duce overall rates of pre-term birth and low birthweight.

5 w concentrations of ambient air pollution on birthweight.

6 and impaired nutrient transport causing low birthweight.

7 erapy reduces rates of preterm birth and low birthweight.

8 al loss (abortions and stillbirths), and low birthweight.

9 ltiple pregnancies than in infants of normal birthweight.

10 for Q3, and 3.56 (1.79-7.10) for Q4 for low birthweight.

11 increase the rate of babies born with a low birthweight.

12 d with increased risk of prematurity and low birthweight.

13 isk factors for under-5 mortality, including birthweight.

14 ren who had been full-term infants of normal birthweight.

15 The primary outcome was birthweight.

16 5% CI 0.90-2.21, I(2)=0.0%, p=0.543) for low birthweight.

17 are associated with maternal anemia and low birthweight.

18 s contribute to racial/ethnic differences in birthweight.

19 eted weeks of gestation or 1000 g or heavier birthweight.

20 llbirth, miscarriage, preterm birth, and low birthweight.

21 rence [RD] -0.05, 95% CI -0.12 to 0.02), low birthweight (0.00, -0.07 to 0.07), and placental malaria

22 Lower birth length (1.9 [1.1-3.2]), lower birthweight (0.5 [0.3-0.9]), and higher birthweight (0.6

23 ower birthweight (0.5 [0.3-0.9]), and higher birthweight (0.6 [0.4-1.0]) were predictive of sensitiza

24 (relative risk 1.50, 95% CI 1.24-1.82), low birthweight (1.62, 1.41-1.86), small for gestational age

25 -2.35, 156/1402 [11%] vs 120/1739 [7%]), low birthweight (1.82, 1.09-3.06, 77/996 [8%] vs 49/1192 [4%

26 Babies who are term SGA low birthweight (10.4 million in these regions) are at risk

27 r in male than female babies in the group of birthweight 1000-1499 g (61.0 [53.8-68..2] vs 49.5 [42.8

28 eral spastic cerebral palsy among infants of birthweight 1000-1499 g.

29 We enrolled very low birthweight (1500 g and lower) infants in the primary co

30 y than all other hospital births to have low birthweight (19.1%; SE, 0.5%; vs 7.0%; SE, 0.2%), have r

31 .7 per DALY averted for moderate risk of low birthweight, $19.4 per DALY averted for low risk, and $4

32 s also suggest an increased risk of term low birthweight (2.62, 1.15-5.93) and preterm low birthweigh

33 quantel did not have a significant effect on birthweight (2.85 kg in both groups, beta=-0.002 [95% CI

34 irthweight (2.62, 1.15-5.93) and preterm low birthweight (3.25, 2.12-4.99).

35 1%] vs 53 [24.0%], p=0.015) and a lower mean birthweight (3163 [SD 642] vs 3341 [606] g, p=0.013) in

36 Prospectively enrolled preterm infants with birthweights 500-1,250 g underwent echocardiogram evalua

37 he 12,355,251 live births were classified by birthweight: 500-1,499 g (very LBW [VLBW], n = 139,608),

38 ient supplements during pregnancy had a mean birthweight 77 g greater than children born to mothers t

39 ong infants less than the 5th percentile for birthweight (a proxy for preterm birth) across the clust

40 Those with a birthweight about 1 SD above average always had the lowe

41 ween maternal anaemia and placental size and birthweight across the normal range for these measures.

42 Smaller birthweight (adjusted odds ratio [aOR]: 0.56 per kg, P <

43 that the Mstn KO rabbits exhibited increased birthweight and a significantly increase in the weight r

44 In view of the apparent association between birthweight and adult weight, obesity prevention efforts

45 We investigated the association between birthweight and all-cause mortality and identified major

46 An increased rate in children of low birthweight and from ethnic minority groups, together wi

47 Among the children who had been normal birthweight and full-term infants, the cromolyn without

48 our status, delivery mode, offspring gender, birthweight and gestational age.

49 trient supplementation would increase infant birthweight and gestational duration.

50 Primary outcome measures were birthweight and gestational duration.

51 e in reducing maternal anaemia and improving birthweight and infant survival in hookworm-endemic regi

52 the previously reported association between birthweight and later CVD.

53 untries of low and middle income to increase birthweight and linear growth during the first 2 years o

54 n pregnancy (IPTp or ITNs) at preventing low birthweight and neonatal mortality under routine program

55 ery, small size for gestational age, and low birthweight and no effect on maternal quality of life, g

56 status and other factors known to influence birthweight and placental size.

57 0.040 to -0.012 mm; P=0.0003) independent of birthweight and potential confounding factors.

58 nt supplementation decreases the risk of low birthweight and potentially improves other infant health

59 7 weeks, <34 weeks, or <32 weeks) and on low birthweight and preterm, premature rupture of membranes.

60 ther potential in utero determinants of both birthweight and risk for type 2 diabetes may yield new m

61 The association between birthweight and risk for type 2 diabetes was strongest a

62 gested a reverse J-shape association between birthweight and risk for type 2 diabetes.

63 risk factors might explain the link between birthweight and risk of IHD in both the individual and t

64 act of adverse pregnancy outcomes (e.g., low birthweight and stillbirth).

65 The association between birthweight and subsequent blood pressure levels has bee

66 aims of a strong inverse association between birthweight and subsequent blood pressure may chiefly re

67 r, a consistent negative association between birthweight and systolic blood pressure was noted from a

68 t since the former is highly correlated with birthweight and the latter with deprivation, we believe

69 ight gain during pregnancy seems to increase birthweight and the offspring's risk of obesity later in

70 ls, we assessed how these outcomes relate to birthweight and to statistically independent measures re

71 eports have suggested an association between birthweight and type 2 diabetes mellitus.

72 Low birthweight and/or respiratory distress were reported in

73 rths (2520 [5%] less than 5th percentile for birthweight) and 50 control clusters with 50,743 livebir

74 cated by decreased time to delivery, reduced birthweight, and 100% mortality.

75 ween malaria prevention in pregnancy and low birthweight, and a Poisson model for the outcome of neon

76 h preterm delivery, early-term delivery, low birthweight, and being small for gestational age.

77 fixed ratios) with similar gestational ages, birthweight, and birth dates were selected from the popu

78 w, moderate, and high background risk of low birthweight, and did a separate analysis for HIV-negativ

79 of non-ophthalmic impairments or disorders, birthweight, and ethnic origin.

80 The primary outcomes were preterm birth, low birthweight, and hospital attendances for asthma.

81 anthelmintic treatment and maternal anaemia, birthweight, and infant mortality in a study of prenatal

82 aternal obesity is associated with increased birthweight, and obesity and premature mortality in adul

83 Infant mortality, low birthweight, and placental malaria were additional outco

84 d after adjustment for socioeconomic status, birthweight, and sex.

85 ing childhood or adolescence on live births, birthweight, and the frequency of congenital malformatio

86 Apgar scores, birthweights, and immediate postpartum health were repor

87 term delivery (<37, <34, and <32 weeks); low birthweight; and preterm, premature rupture of membranes

88 Complications of pregnancy linked to low birthweight are associated with an increased risk of sub

89 pregnancy complications associated with low birthweight are related to risk of subsequent IHD in the

90 Mean birthweight at delivery was 3463 g (SD 660) in the place

91 was associated with an increased risk of low birthweight at term (adjusted odds ratio [OR] 1.18, 95%

92 The primary outcome of interest was low birthweight at term (weight <2500 g at birth after 37 we

93 A substantial proportion of cases of low birthweight at term could be prevented in Europe if urba

94 crease of 22% (95% CI 8-33%) in cases of low birthweight at term.

95 e also associated with increased risk of low birthweight at term.

96 More low birthweight babies were born to women who took antioxida

97 Of 18 million low-birthweight babies, 59% were term-SGA and 41% were prete

98 ociated with severe maternal anaemia and low-birthweight babies.

99 x and neurological subtype in infants with a birthweight below 1000 g and 1000-1499 g in the period 1

100 ivebirths; p=0.0025) but not in the group of birthweight below 1000 g.

101 and small-for-gestational-age (SGA) neonate (birthweight below the fifth percentile).

102 ssociation between pregnancy weight gain and birthweight (beta 7.35, 95% CI 7.10-7.59, p<0.0001).

103 ified milk or formula, and infants born with birthweight between 2500 g and 3000 g.

104 There were differences in birthweight between countries, e.g., India had significa

105 ely each of the perinatal factors, including birthweight, birth length, parental age at delivery, ges

106 Other factors such as birthweight, breastfeeding, socioeconomic status and reg

107 men showed increased length of gestation and birthweight, but did not have a higher risk of macrosomi

108 ternal immunisation reduced the rates of low birthweight by 15% (95% CI 3-25) in both cohorts combine

109 and a relative fall in the proportion of low birthweight by 25%.

110 ll size for gestational age (<5th customised birthweight centile).

111 -gestational-age infants (>/=90th customised birthweight centile).

112 r-gestational-age infants (</=5th customised birthweight centile; 6% vs 5%) did not differ between gr

113 The underlying lifetime risk of low birthweight changes slowly with decreasing transmission,

114 abnormal fetal growth and development: (low birthweight, congenital malformations, reduced head circ

115 We studied 13515 infants of all birthweights consecutively admitted to 54 randomly selec

116 perinatal outcome (lower gestational age and birthweight, containing all cases of perinatal mortality

117 es born preterm and SGA rather than with low birthweight could guide prevention and management strate

118 obtained life expectancy, mortality, and low birthweight data from the WHO Statistical Information Sy

119 edible interval [CrI] 530,000-1,240,000) low birthweight deliveries per year.

120 f heavy colonisation with GBS in preterm low-birthweight deliveries.

121 associated with poor outcomes including low birthweight delivery and maternal anemia.

122 7-like variants delivered infants with lower birthweight (difference: -267.99 g; 95% Confidence Inter

123 No such birthweight differences were observed between newborns f

124 g countries, the risk of prematurity and low birthweight doubles when conception occurs within 6 mont

125 predicted to greatly reduce incidence of low birthweight, especially in primigravidae.

126 A male baby with a normal birthweight for gestational age (1775 g) and with APGAR

127 Babies of 32-42 weeks' gestation with a birthweight for gestational age below the 10th percentil

128 ess and death is increased in infants of low birthweight for gestational age, but the underlying phys

129 way function is diminished in infants of low birthweight for gestational age, independent of exposure

130 6, 0.73-1.01, p=0.060) decreased risk of low birthweight for those in the MMN group, with a 33% (RR 0

131 0 g weight increase; p=0.001) independent of birthweight, gestation, neonatal morbidity, and demograp

132 ociations between maternal age and offspring birthweight, gestational age at birth, height-for-age an

133 2011, and for whom information about infant birthweight, gestational age, and sex was available.

134 ca, and Latin America that recorded data for birthweight, gestational age, and vital statistics throu

135 ars) maternal age were associated with lower birthweight, gestational age, child nutritional status,

136 TN (e.g., pre-eclampsia) and infant factors (birthweight, gestational age, erythropoietin use, and zo

137 ed odds ratio 2.4, 95% CI 1.2-4.9), neonatal birthweight greater than 4.0 kg (2.3, 1.3-3.8), and occi

138 The association of birthweight group with mortality in infancy (<1 y of age

139 fied major causes of mortality for different birthweight groups.

140 revalent in the 1,500-2,499 g and >/=2,500 g birthweight groups.

141 neonates of 32 weeks' gestation or more (or birthweight >/=1500 g) with livebirth denominator data,

142 and three primary outcomes (LGA [defined as birthweight >90th percentile for gestational age], high

143 Large placental size and low birthweight have been implicated as factors predicting h

144 ancy leads to adverse outcomes including low birthweight; however, contemporary estimates of the pote

145 (ITNs) significantly reduce the risk of low birthweight in regions of stable malaria transmission.

146 Pooled RRs for babies who were SGA (with birthweight in the lowest tenth percentile of the refere

147 small-for-gestational-age (SGA; babies with birthweight in the lowest third percentile and between t

148 However, low birthweight includes babies born preterm and with fetal

149 clinical gestational age is associated with birthweight independent of gestational age, sex, and anc

150 ernal weight gain during pregnancy increases birthweight independently of genetic factors.

151 in two meridians was performed on 222 normal-birthweight infant subjects at 3 and 9 months of age.

152 ry preterm (1.53, 1.22-1.92), or to have low-birthweight infants (1.30, 1.04-1.62) than were those wh

153 ke it an important intervention for very low birthweight infants admitted to hospital in developing c

154 because of the improved survival of very low birthweight infants and their need for invasive monitori

155 ased use of antenatal corticosteroids in low-birthweight infants in the intervention groups, neonatal

156 In Guinea-Bissau, low-birthweight infants were randomized to early (interventi

157 ear to be at risk for early delivery and low birthweight infants, and women with ulcerative colitis m

158 In a randomized trial of 3003 very low birthweight infants, display of the HeRO score reduced m

159 New studies in very low-birthweight infants, infants with congenital heart disea

160 st nosocomial infections in preterm very low birthweight infants.

161 recede necrotising enterocolitis in very low birthweight infants.

162 ority trial with healthy, full-term (>2.5 kg birthweight) infants aged 8 weeks (+/- 7 days) at six we

163 ty of children younger than 5 years, and low birthweight is a crucial underlying factor.

164 Low birthweight is a significant risk factor for neonatal an

165 Low birthweight is an important indirect cause of death.

166 Low birthweight is associated with insulin resistance, hyper

167 es from developing country settings in which birthweight is either not available or accurate.

168 A prominent cause of low birthweight is infection with Plasmodium falciparum duri

169 Birthweight is inversely associated with risk for type 2

170 seems to be more common in term babies whose birthweight is low for their gestational age at delivery

171 These findings suggest that birthweight is of little relevance to blood pressure lev

172 It had been estimated that a 1 kg higher birthweight is typically associated with a 2-4 mm Hg low

173 reterm delivery (S-shaped, p<0.0001) and low birthweight (J-shaped, p=0.0001); the adjusted odds rati

174 000 (94,000-236,000 95% crI) preventable low birthweight (LBW) deliveries.

175 Low birthweight (LBW) is associated with increased mortality

176 Among children who had been of low birthweight (LBW) or had been premature infants, greater

177 en periodontal status and preterm birth, low birthweight (LBW) or preeclampsia.

178 ITNs to pregnant women and the impact on low birthweight (LBW).

179 nfection during pregnancy on the risk of low birthweight (LBW; <2,500 g) may depend upon maternal nut

180 ve GWG showed increased length of gestation, birthweight, length, and head circumference, and were mo

181 regnancy BMI or GWG and length of gestation, birthweight, length, and head circumference.

182 born with cerebral palsy; 414 (26%) were of birthweight less than 1000 g and 317 (20%) were from mul

183 prevalence of cerebral palsy in children of birthweight less than 1500 g has fallen, which has impor

184 estriction, and not all these infants have a birthweight less than 2500 g.

185 eeks or 41 weeks or more; maternal diabetes; birthweight less than 500 g or more than 7000 g; and mis

186 sociations between income inequality and low birthweight, life expectancy, self-rated health, and age

187 cting as an early life stressor, we examined birthweight, litter size, maternal cannibalism, and epig

188 ted with increased risk of RA include higher birthweight, living in the northeastern United States co

189 more likely to be small for gestational age (birthweight < 10 percentile for gestational age; 18.2% v

190 performed in 37 consecutive FGR (defined as birthweight <10th centile) and 37 normally grown fetuses

191 eclampsia, small-for-gestational-age infant (birthweight <10th percentile), pregnancy loss, or venous

192 a, and our main secondary endpoints were low birthweight (<2.5 kg) and small size for gestational age

193 red rates of livebirth, multiple births, low birthweight (<2.5 kg), preterm birth (<37 weeks), and se

194 : -466.43 g,-69.55 g) and higher odds of low birthweight (<2500 g) (Odds Ratio [OR] 5.41; 95% CI:0.99

195 Babies with low birthweight (<2500 g) are at increased risk of early mor

196 0-180 days postpartum, the incidence of low birthweight (<2500 g), and the incidence of laboratory-c

197 GA and preterm-SGA), and the relation to low birthweight (<2500 g), in 138 countries of low and middl

198 sometimes has adverse outcomes including low birthweight (<2500 g), pre-term birth (<37 weeks), growt

199 gnificant associations of amblyopia with low birthweight (<2500 g), preterm birth (<37 weeks), matern

200 .72, 100/704 [14%] vs 1494/27 674 [5%]), low birthweight (<2500 g; 2.53, 1.19-5.36, 32/261 [12%] vs 9

201 (composite of small for gestational age, low birthweight [<2,500 g], or preterm birth [<37 wk]) in pa

202 tal health and risk for preterm birth or low birthweight, making periodontitis a potentially modifiab

203 (NTR4153), 11 NEC cases were gestational age/birthweight matched with controls (ratio of 1:2).

204 in, pre-pregnancy BMI, preterm delivery, low birthweight, maternal antibiotic use, and infection duri

205 ncy at birth, infant mortality, low and high birthweight, maternal mortality, nutritional status, edu

206 Parity was an important determinant of birthweight (mean standard deviation score -0.13 [SD 0.9

207 Low birthweight, measures of insulin resistance in life, and

208 th, very small for gestational age, very low birthweight, miscarriage, or neonatal death, although fe

209 he risks of MiP and malaria-attributable low birthweight (mLBW) in unprotected pregnancies (i.e., tho

210 analyses included cesarean-section delivery, birthweight, multiple birth, and infant survival status.

211 C) in very low birthweight (VLBW) and normal birthweight (NBW) infants are rare.

212 In 2002-2004, we randomized 4345 normal birthweight neonates to NVAS (50 000 IU retinyl palmitat

213 have improved the survival rate in very low birthweight neonates.

214 Higher-birthweight newborns from HbAC mothers may have a surviv

215 s with younger maternal age remained for low birthweight (odds ratio [OR] 1.18 (95% CI 1.02-1.36)], p

216 Mean birthweight of 742 babies with mothers assigned to FNP w

217 gned to FNP was 3217.4 g (SD 618.0), whereas birthweight of 768 babies assigned to usual care was 319

218 ticipants were healthy newborn babies with a birthweight of at least 2.5 kg, for whom informed consen

219 ore pregnancies for each woman predicted the birthweight of her offspring, using a within-subject des

220 Birthweight of infants of women who had received two dos

221 We regarded SGA as a birthweight of less than the 10th percentile for gestati

222 Average birthweight of non-Hispanic white infants was 3381 g, wh

223 tobacco use by the mother at late pregnancy, birthweight of the baby, the proportion of women with a

224 The median gestational age at birth and birthweight of the infants were 27 weeks and 909 g, resp

225 if any, on pregnancy loss, live births, and birthweight of treatment for cancer diagnosed during chi

226 ined at 48 hours postpartum in newborns with birthweights of 2,250 g or more.

227 ody mass in anthropoids are used to estimate birthweights of extinct hominid taxa.

228 The negative effect of birthweight on systolic blood pressure has been suggeste

229 diabetes at baseline and reported their own birthweight on the 1992 questionnaire.

230 Cigarette smoking influenced birthweight only.

231 etal death in the third trimester (>/=1000 g birthweight or >/=28 completed weeks of gestation).

232 were estimated worldwide in 2008 (>/=1000 g birthweight or >/=28 weeks of gestation).

233 ons with opportunistic pathogens in very low birthweight or immunocompromised neonates.

234 -like illness, influenza in infants, and low birthweight over the entire course of the study, indicat

235 nfant characteristics (sex, gestational age, birthweight, parity and breast feeding), maternal charac

236 ficantly associated with reduced odds of low birthweight (PE 21%, 14-27; IRR 0.792, 0.732-0.857), as

237 Metformin has no significant effect on birthweight percentile in obese pregnant women.

238 estational age, parity, and sex-standardised birthweight percentile of liveborn babies delivered at 2

239 Low birthweight percentile was associated with increased fov

240 be an important risk factor for preterm low birthweight (PLBW).

241 of gestation, induced programming of altered birthweight, postnatal growth rate, hypertension and org

242 Low birthweight, pre-term birth and pre-eclampsia have been

243 gestational age, small for gestational age, birthweight, pregnancy loss or miscarriage, or pre-eclam

244 Very low birthweight premature infants have compromised skin barr

245 offspring of these women are at risk for low birthweight, premature (< 36 weeks gestation) birth, and

246 r creams as protective biofilms for very low birthweight preterm infants.

247 birthweight, very low birthweight, term low birthweight, preterm low birthweight, small for gestatio

248 ociated with delivering a baby in the lowest birthweight quintile for gestational age (adjusted hazar

249 atal mortality rate) (cubic spline), log(low birthweight rate) (cubic spline), log(gross national inc

250 th uncomplicated pregnancies (individualized birthweight ratio [IBR] >20th percentile and delivery >3

251 sk of breast cancer was noted with increased birthweight (relative risk [RR] 1.15 [95% CI 1.09-1.21])

252 ulthood compared to average birth length and birthweight, respectively.

253 ements resulted in greater reductions in low birthweight (RR 0.81, 95% CI 0.74-0.89; p value for inte

254 Both mean gestational age and mean birthweight seems significantly greater for liver transp

255 sability-adjusted life-years (DALYs) for low birthweight, severe to moderate anaemia, and clinical ma

256 stic regression models, adjusted for child's birthweight, sex, age, ethnic origin, parental education

257 ined after adjustment for centre, gestation, birthweight, sex, plurality, and use of antenatal steroi

258 6% (14% [4-24]), and 12 (23%) of 52 had low birthweight singleton offspring compared with a normal r

259 herapy is associated with preterm birth, low birthweight, small for gestational age, and stillbirth,

260 The risk of very low birthweight, small for gestational age, severe small for

261 rthweight, term low birthweight, preterm low birthweight, small for gestational age, very small for g

262 er, date of birth, gestational age at birth, birthweight, stage of ROP at presentation, initial treat

263 including gender, gestational age at birth, birthweight, stage of ROP at presentation, prior treatme

264 iorespiratory disease is associated with low birthweight suggesting the importance of the development

265 ery preterm birth, low birthweight, very low birthweight, term low birthweight, preterm low birthweig

266 Newborns from HbAC mothers had higher birthweights than those from HbAA mothers among women in

267 babies with normal physical examinations and birthweights that were appropriate for gestational age.

268 acental infection and associated risk of low birthweight to estimate the number of women who would ha

269 n pregnancies, we related placental size and birthweight to maternal iron status, socioeconomic statu

270 ial reductions in neonatal mortality and low birthweight under routine malaria control programme cond

271 association between maternal weight gain and birthweight using state-based birth registry data that a

272 s did not account for significant portion of birthweight variations for any race.

273 omes: preterm birth, very preterm birth, low birthweight, very low birthweight, term low birthweight,

274 and early childhood caries (ECC) in very low birthweight (VLBW) and normal birthweight (NBW) infants

275 ern Europe, is higher in infants of very low birthweight (VLBW)--those born weighing less than 1500 g

276 very was 30.7 weeks (IQR 29.1-32.1) and mean birthweight was 1019 g (SD 322).

277 f these neonates was 35.0 weeks (SD 4.6) and birthweight was 2384 g (1007).

278 Mean birthweight was 2733 g (SD 422) in the control group and

279 The median birthweight was 3,300 g (IQR 2,980-3,615).

280 Birthweight was ascertained at the end of follow-up.

281 A 1 kg higher birthweight was associated with a slower mean increase i

282 t associated with dysglycaemia, but a higher birthweight was associated with decreased risk of the di

283 Birthweight was available for 523/600 infants in the con

284 A higher birthweight was consistently associated with an adult bo

285 No significant effect on low birthweight was identified (six studies, >1.9 million in

286 Birthweight was not associated with diastolic blood pres

287 Pup birthweight was unaffected by C. rectus exposure, but le

288 s for multiple birth, preterm birth, and low birthweight were all smaller in older than in younger wo

289 had resulted and data on gestational age and birthweight were complete).

290 ks' gestation and below the 10th centile for birthweight were randomised within 72 h of birth to rece

291 Severe ROP and low birthweight were related to neuronal and axonal damage i

292 69 (83%) of 83 cases with known birthweight were small for gestational age, compared wit

293 Preterm birth and low birthweight were the most common adverse pregnancy outco

294 atally to maternal smoking who, according to birthweight, were either small (SGA; n = 38) or appropri

295 s of pregnancy was associated with increased birthweight when compared with a standard iron and folic

296 on at delivery and health outcomes including birthweight, which is also determined by a wide range of

297 ; maternal mortality in ten populations; low birthweight with the rate difference greater than 2% in

298 e greater than 2% in three populations; high birthweight with the rate difference greater than 2% in

299 cation hypothesis and to compare results for birthweight with those for childhood social class.

300 n coefficients of systolic blood pressure on birthweight (with 48 further studies that reported only